Abstract
Coenzyme Q10 (CoQ10) is a lipophilic component of the mitochondrial respiratory enzyme chain, which transfers electrons to complex III (cytochrome bc1 complex) from complex I (NADH-CoQ reductase), complex II (succinate dehydrogenase), and from the oxidation of fatty acids and branched-chain amino acids via flavin-linked dehydrogenases. Additional cellular functions of CoQ10 have been described. Deficiency of CoQ10 in muscle has been identified in patients with a spectrum of encephalomyopathies ranging from predominant cerebellar ataxia to pure myopathy. In a family with two children affected by infantile-onset encephalomyopathy and nephropathy, the first mutation in a CoQ biosynthetic gene, COQ2, was identified, thus proving the existence of primary CoQ10 deficiency. This article reviews the current state-of-knowledge regarding biochemical and molecular genetic features of inherited CoQ10 deficiency.
Keywords: para-hydroxybenzoate (PHB), S. cerevisiae, C. elegans, nuclear DNA (nDNA), ataxia oculomotor apraxia 1 (AOA1)
Current Genomics
Title: Genetics of Primary CoQ10 Deficiency
Volume: 7 Issue: 6
Author(s): A. B. Naini, C. M. Quinzii, P. Navas, S. DiMauro and M. Hirano
Affiliation:
Keywords: para-hydroxybenzoate (PHB), S. cerevisiae, C. elegans, nuclear DNA (nDNA), ataxia oculomotor apraxia 1 (AOA1)
Abstract: Coenzyme Q10 (CoQ10) is a lipophilic component of the mitochondrial respiratory enzyme chain, which transfers electrons to complex III (cytochrome bc1 complex) from complex I (NADH-CoQ reductase), complex II (succinate dehydrogenase), and from the oxidation of fatty acids and branched-chain amino acids via flavin-linked dehydrogenases. Additional cellular functions of CoQ10 have been described. Deficiency of CoQ10 in muscle has been identified in patients with a spectrum of encephalomyopathies ranging from predominant cerebellar ataxia to pure myopathy. In a family with two children affected by infantile-onset encephalomyopathy and nephropathy, the first mutation in a CoQ biosynthetic gene, COQ2, was identified, thus proving the existence of primary CoQ10 deficiency. This article reviews the current state-of-knowledge regarding biochemical and molecular genetic features of inherited CoQ10 deficiency.
Export Options
About this article
Cite this article as:
Naini B. A., Quinzii M. C., Navas P., DiMauro S. and Hirano M., Genetics of Primary CoQ10 Deficiency, Current Genomics 2006; 7(6) . https://dx.doi.org/10.2174/138920206778948682
DOI https://dx.doi.org/10.2174/138920206778948682 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Retraction Note: Phytochemicals from Plants to Combat Cardiovascular Disease
Current Medicinal Chemistry Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets Do Adult Stem Cells Ameliorate the Damaged Myocardium? Human Cord Blood as a Potential Source of Stem Cells
Current Vascular Pharmacology Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Current Vascular Pharmacology Sarcoidosis in Pregnancy and Postpartum Period
Current Respiratory Medicine Reviews Biomarkers in Acute Heart Failure Syndromes: An Update
Current Cardiology Reviews Metabolic Features of Alcoholic Liver Disease
Reviews on Recent Clinical Trials The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance
Current Vascular Pharmacology Sudden Unexpected Death in Infancy and the Dilemma of Defining the Sudden Infant Death Syndrome
Current Pediatric Reviews Molecular Basis of Cardioprotection by Erythropoietin
Current Molecular Pharmacology Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety The Role of Autophagy in Subarachnoid Hemorrhage: An Update
Current Neuropharmacology Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry Risk Stratification for Sudden Cardiac Death: Current Approaches and Predictive Value
Current Cardiology Reviews